(17314506), R. L., (17314509), E. M., (17314512), A. L., (17314515), N. G., (17314518), I. C., (17314521), A. A., . . . (17314731), D. V. (2025). Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Παραπομπή σε μορφή Chicago (17η εκδ.)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.
Παραπομπή σε μορφή MLA (9th εκδ.)(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.